{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T07:12:02Z","timestamp":1793689922088,"version":"4.5.1"},"reference-count":37,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.m2023.0069","type":"journal-article","created":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T04:13:23Z","timestamp":1682482403000},"source":"Crossref","is-referenced-by-count":4,"title":["Thyroid dysfunction in peri- and postmenopausal women\u2014cumulative risks"],"prefix":"10.3238","author":[{"given":"Karin","family":"Frank-Raue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedhelm","family":"Raue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2023,5,5]]},"reference":[{"key":"10.3238\/arztebl.m2023.0069_ref1","doi-asserted-by":"crossref","unstructured":"El Khoudary SR, Aggarwal B, Beckie TM, et al.: Menopause transition and cardiovascular disease risk: implications for timing of early prevention: a scientific statement from the American Heart Association. Circulation 2020; 142: e506–e32.","DOI":"10.1161\/CIR.0000000000000912"},{"key":"10.3238\/arztebl.m2023.0069_ref2","doi-asserted-by":"crossref","unstructured":"The North American Menopause Society‘‘ Editorial Panel: Management of osteoporosis in postmenopausal women: the 2021 position statement of The North American Menopause Society. Menopause 2021; 28: 973–97.","DOI":"10.1097\/GME.0000000000001831"},{"key":"10.3238\/arztebl.m2023.0069_ref3","doi-asserted-by":"crossref","unstructured":"Volzke H, Ludemann J, Robinson DM, et al.: The prevalence of undiagnosed thyroid disorders in a previously iodine-deficient area. Thyroid 2003; 13: 803–10.","DOI":"10.1089\/105072503768499680"},{"key":"10.3238\/arztebl.m2023.0069_ref4","doi-asserted-by":"crossref","unstructured":"Khattak RM, Ittermann T, Nauck M, Below H, Volzke H: Monitoring the prevalence of thyroid disorders in the adult population of Northeast Germany. Popul Health Metr 2016; 14: 39.","DOI":"10.1186\/s12963-016-0111-3"},{"key":"10.3238\/arztebl.m2023.0069_ref5","doi-asserted-by":"crossref","unstructured":"Canaris GJ, Manowitz NR, Mayor G, Ridgway EC: The Colorado thyroid disease prevalence study. Arch Intern Med 2000; 160: 526–34.","DOI":"10.1001\/archinte.160.4.526"},{"key":"10.3238\/arztebl.m2023.0069_ref6","doi-asserted-by":"crossref","unstructured":"Flynn RW, Bonellie SR, Jung RT, MacDonald TM, Morris AD, Leese GP: Serum thyroid-stimulating hormone concentration and morbidity from cardiovascular disease and fractures in patients on long-term thyroxine therapy. J Clin Endocrinol Metab 2010; 95: 186–93.","DOI":"10.1210\/jc.2009-1625"},{"key":"10.3238\/arztebl.m2023.0069_ref7","doi-asserted-by":"crossref","unstructured":"Jonklaas J, Bianco AC, Bauer AJ, et al.: Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement. Thyroid 2014; 24: 1670–751.","DOI":"10.1089\/thy.2014.0028"},{"key":"10.3238\/arztebl.m2023.0069_ref8","doi-asserted-by":"crossref","unstructured":"Slopien R, Owecki M, Slopien A, Bala G, Meczekalski B: Climacteric symptoms are related to thyroid status in euthyroid menopausal women. J Endocrinol Invest 2020; 43: 75–80.","DOI":"10.1007\/s40618-019-01078-7"},{"key":"10.3238\/arztebl.m2023.0069_ref9","doi-asserted-by":"crossref","unstructured":"Davis SR, Baber RJ: Treating menopause — MHT and beyond. Nat Rev Endocrinol 2022; 18: 490–502.","DOI":"10.1038\/s41574-022-00685-4"},{"key":"10.3238\/arztebl.m2023.0069_ref10","doi-asserted-by":"crossref","unstructured":"Avis NE, Crawford SL, Greendale G, et al.: Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Intern Med 2015; 175: 531–9.","DOI":"10.1001\/jamainternmed.2014.8063"},{"key":"10.3238\/arztebl.m2023.0069_ref11","doi-asserted-by":"crossref","unstructured":"Weidner K, Richter J, Bittner A, Stobel-Richter Y, Brahler E: [Menopausal complaints across the lifespan? Findings of a German representative survey]. Psychother Psychosom Med Psychol 2012; 62: 266–75.","DOI":"10.1055\/s-0032-1311561"},{"key":"10.3238\/arztebl.m2023.0069_ref12","doi-asserted-by":"crossref","unstructured":"Boelaert K, Torlinska B, Holder RL, Franklyn JA: Older subjects with hyperthyroidism present with a paucity of symptoms and signs: a large cross-sectional study. J Clin Endocrinol Metab 2010; 95: 2715–26.","DOI":"10.1210\/jc.2009-2495"},{"key":"10.3238\/arztebl.m2023.0069_ref13","doi-asserted-by":"crossref","unstructured":"Parle JV, Maisonneuve P, Sheppard MC, Boyle P, Franklyn JA: Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet 2001; 358: 861–5.","DOI":"10.1016\/S0140-6736(01)06067-6"},{"key":"10.3238\/arztebl.m2023.0069_ref14","doi-asserted-by":"crossref","unstructured":"Muller P, Leow MK, Dietrich JW: Minor perturbations of thyroid homeostasis and major cardiovascular endpoints—physiological mechanisms and clinical evidence. Front Cardiovasc Med 2022; 9: 942971.","DOI":"10.3389\/fcvm.2022.942971"},{"key":"10.3238\/arztebl.m2023.0069_ref15","doi-asserted-by":"crossref","unstructured":"Rodondi N, den Elzen WP, Bauer DC, et al.: Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA 2010; 304: 1365–74.","DOI":"10.1001\/jama.2010.1361"},{"key":"10.3238\/arztebl.m2023.0069_ref16","doi-asserted-by":"crossref","unstructured":"Moon S, Kim MJ, Yu JM, Yoo HJ, Park YJ: Subclinical hypothyroidism and the risk of cardiovascular disease and all-cause mortality: a meta-analysis of prospective cohort studies. Thyroid 2018; 28: 1101–10.","DOI":"10.1089\/thy.2017.0414"},{"key":"10.3238\/arztebl.m2023.0069_ref17","doi-asserted-by":"crossref","unstructured":"Stott DJ, Rodondi N, Bauer DC, Group TS: Thyroid hormone therapy for older adults with subclinical hypothyroidism. N Engl J Med 2017; 377: e20.","DOI":"10.1056\/NEJMc1709989"},{"key":"10.3238\/arztebl.m2023.0069_ref18","doi-asserted-by":"crossref","unstructured":"Razvi S, Weaver JU, Butler TJ, Pearce SH: Levothyroxine treatment of subclinical hypothyroidism, fatal and nonfatal cardiovascular events, and mortality. Arch Intern Med 2012; 172: 811–7.","DOI":"10.1001\/archinternmed.2012.1159"},{"key":"10.3238\/arztebl.m2023.0069_ref19","doi-asserted-by":"crossref","unstructured":"Andersen MN, Olsen AM, Madsen JC, et al.: Levothyroxine substitution in patients with subclinical hypothyroidism and the risk of myocardial infarction and mortality. PLoS One 2015; 10: e0129793.","DOI":"10.1371\/journal.pone.0129793"},{"key":"10.3238\/arztebl.m2023.0069_ref20","doi-asserted-by":"crossref","unstructured":"Biondi B, Cappola AR, Cooper DS: Subclinical hypothyroidism: a review. JAMA 2019; 322: 153–60.","DOI":"10.1001\/jama.2019.9052"},{"key":"10.3238\/arztebl.m2023.0069_ref21","doi-asserted-by":"crossref","unstructured":"Pearce SH, Brabant G, Duntas LH, et al.: 2013 ETA guideline: management of subclinical hypothyroidism. Eur Thyroid J 2013; 2: 215–28.","DOI":"10.1159\/000356507"},{"key":"10.3238\/arztebl.m2023.0069_ref22","doi-asserted-by":"crossref","unstructured":"Muka T, Oliver-Williams C, Kunutsor S, et al.: Association of age at onset of menopause and time since onset of menopause with cardiovascular outcomes, intermediate vascular traits, and all-cause mortality: a systematic review and meta-analysis. JAMA Cardiol 2016; 1: 767–76.","DOI":"10.1001\/jamacardio.2016.2415"},{"key":"10.3238\/arztebl.m2023.0069_ref23","doi-asserted-by":"crossref","unstructured":"Rossouw JE, Anderson GL, Prentice RL, et al.: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women‘s Health Initiative randomized controlled trial. JAMA 2002; 288: 321–33.","DOI":"10.1001\/jama.288.3.321"},{"key":"10.3238\/arztebl.m2023.0069_ref24","doi-asserted-by":"crossref","unstructured":"Manson JE, Aragaki AK, Rossouw JE, et al.: Menopausal hormone therapy and long-term all-cause and cause-specific mortality: The Women‘s Health Initiative randomized trials. JAMA 2017; 318: 927–38.","DOI":"10.1001\/jama.2017.11217"},{"key":"10.3238\/arztebl.m2023.0069_ref25","unstructured":"Manson JE, Chlebowski RT, Stefanick ML, et al.: Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women‘s Health Initiative randomized trials. JAMA 2013; 310: 1353–68."},{"key":"10.3238\/arztebl.m2023.0069_ref26","doi-asserted-by":"crossref","unstructured":"Schierbeck LL, Rejnmark L, Tofteng CL, et al.: Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial. BMJ 2012; 345: e6409.","DOI":"10.1136\/bmj.e6409"},{"key":"10.3238\/arztebl.m2023.0069_ref27","doi-asserted-by":"crossref","unstructured":"Maas A, Rosano G, Cifkova R, et al.: Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists, gynaecologists, and endocrinologists. Eur Heart J 2021; 42: 967–84.","DOI":"10.1093\/eurheartj\/ehaa1044"},{"key":"10.3238\/arztebl.m2023.0069_ref28","doi-asserted-by":"crossref","unstructured":"Shifren JL, Desindes S, McIlwain M, Doros G, Mazer NA: A randomized, open-label, crossover study comparing the effects of oral versus transdermal estrogen therapy on serum androgens, thyroid hormones, and adrenal hormones in naturally menopausal women. Menopause 2007; 14: 985–94.","DOI":"10.1097\/gme.0b013e31803867a"},{"key":"10.3238\/arztebl.m2023.0069_ref29","doi-asserted-by":"crossref","unstructured":"Arafah BM: Increased need for thyroxine in women with hypothyroidism during estrogen therapy. N Engl J Med 2001; 344: 1743–9.","DOI":"10.1056\/NEJM200106073442302"},{"key":"10.3238\/arztebl.m2023.0069_ref30","doi-asserted-by":"crossref","unstructured":"Karlamangla AS, Burnett-Bowie SM, Crandall CJ: Bone health during the menopause transition and beyond. Obstet Gynecol Clin North Am 2018; 45: 695–708.","DOI":"10.1016\/j.ogc.2018.07.012"},{"key":"10.3238\/arztebl.m2023.0069_ref31","doi-asserted-by":"crossref","unstructured":"Marjoribanks J, Farquhar C, Roberts H, Lethaby A, Lee J: Long-term hormone therapy for perimenopausal and postmenopausal women. Cochrane Database Syst Rev 2017; 1: CD004143.","DOI":"10.1002\/14651858.CD004143.pub5"},{"key":"10.3238\/arztebl.m2023.0069_ref32","doi-asserted-by":"crossref","unstructured":"Schini M, Vilaca T, Gossiel F, Salam S, Eastell R: Bone turnover markers: basic biology to clinical applications. Endocr Rev 2023; 00:1–57.","DOI":"10.1210\/endrev\/bnac031"},{"key":"10.3238\/arztebl.m2023.0069_ref33","doi-asserted-by":"crossref","unstructured":"Vestergaard P, Mosekilde L: Hyperthyroidism, bone mineral, and fracture risk — a meta-analysis. Thyroid 2003; 13: 585–93.","DOI":"10.1089\/105072503322238854"},{"key":"10.3238\/arztebl.m2023.0069_ref34","doi-asserted-by":"crossref","unstructured":"Vestergaard P, Mosekilde L: Fractures in patients with hyperthyroidism and hypothyroidism: a nationwide follow-up study in 16,249 patients. Thyroid 2002; 12: 411–9.","DOI":"10.1089\/105072502760043503"},{"key":"10.3238\/arztebl.m2023.0069_ref35","doi-asserted-by":"crossref","unstructured":"Blum MR, Bauer DC, Collet TH, et al.: Subclinical thyroid dysfunction and fracture risk: a meta-analysis. JAMA 2015; 313: 2055–65.","DOI":"10.1001\/jama.2015.5161"},{"key":"10.3238\/arztebl.m2023.0069_ref36","doi-asserted-by":"crossref","unstructured":"Haugen BR, Alexander EK, Bible KC, et al.: 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2016; 26: 1–133.","DOI":"10.1089\/thy.2015.0020"},{"key":"10.3238\/arztebl.m2023.0069_ref37","doi-asserted-by":"crossref","unstructured":"Brancatella A, Marcocci C: TSH suppressive therapy and bone. Endocr Connect 2020; 9: R158–72.","DOI":"10.1530\/EC-20-0167"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2023.0069","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T04:13:35Z","timestamp":1682482415000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2023.0069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,5]]},"references-count":37,"URL":"https:\/\/doi.org\/10.3238\/arztebl.m2023.0069","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,5]]}}}